Akari Therapeutics (AKTX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Akari Therapeutics

    NASDAQ: AKTX · Real-Time Price · USD
    0.92
    -0.01 (-1.47%)
    At close: Oct 03, 2025, 3:59 PM

    Akari Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.00 -0.00 -0.00 -0.00
    PEG Ratio
    		 -0.00 0.00 0.00 0.00
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 0.00 -0.07 0.02 0.01
    P/FCF Ratio
    		 -0.00 -0.00 -0.00 -0.00
    P/OCF Ratio
    		 -0.00 -0.00 -0.00 -0.00
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.15 n/a n/a n/a
    Quick Ratio
    		 0.15 0.95 1.35 1.91
    Current Ratio
    		 0.15 0.95 1.15 1.91
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 88.70 n/a n/a n/a
    Return on Equity
    		 -0.89 43.70 -3.89 -3.17
    Return on Assets
    		 -0.39 -2.3 -0.5 -1.51
    Return on Invested Capital
    		 -0.64 73.39 -5.06 -3.13
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist